| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 33 |
| 1 | RITUXIMAB | 31 |
| 2 | TACROLIMUS | 30 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 30 |
| 4 | TACROLIMUS OINTMENT 0.1% | 30 |
| 5 | CYCLOPHOSPHAMIDE | 28 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 28 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 28 |
| 8 | METHOTREXATE SODIUM | 25 |
| 9 | METHOTREXATE | 24 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 92 |
| 1 | CD20-directed Cytolytic Antibody [EPC] | 34 |
| 2 | Alkylating Drug [EPC] | 31 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 31 |
| 4 | Proton Pump Inhibitor [EPC] | 30 |
| 5 | Kinase Inhibitor [EPC] | 25 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 24 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 21 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 9 | Vitamin C [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 1 | Gamma Secretase Inhibitor [EPC] | 2 | 0.0022 |
| 2 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 3 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 4 | Allylamine Antifungal [EPC] | 5 | 0.0007 |
| 5 | Anthelmintic [EPC] | 2 | 0.0007 |
| 6 | Antiprotozoal [EPC] | 7 | 0.0007 |
| 7 | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] | 2 | 0.0006 |
| 8 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 2 | 0.0005 |
| 9 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |